LakeShore Biopharma Co., Ltd. SCHEDULE 13D/A
Accession 0001213900-25-103261
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 8:05 AM ET
Size
392.2 KB
Accession
0001213900-25-103261
Documents
- SCHEDULEprimary_doc.xml
- EX-99.1ea026254001ex99-1_crystal.htm
EXECUTIVE OFFICERS AND DIRECTORS
- EX-99.2ea026254001ex99-2_crystal.htm
JOINT FILING AGREEMENT DATED OCTOBER 29, 2025 BY AND AMONG THE REPORTING PERSONS
- EX-99.3ea026254001ex99-3_crystal.htm
PROPOSAL DATED AUGUST 18, 2025 FROM OCEANPINE TO THE BOARD OF DIRECTORS OF THE ISSUER
- EX-99.4ea026254001ex99-4_crystal.htm
CONSORTIUM AGREEMENT DATED AUGUST 26, 2025 BY AND AMONG OCEANPINE INVESTMENT, OCEANPINE CAPITAL, AND CRYSTAL INVESTMENT
- EX-99.5ea026254001ex99-5_crystal.htm
REVISED PROPOSAL DATED AUGUST 26, 2025 FROM OCEANPINE AND CRYSTAL INVESTMENT TO THE BOARD OF DIRECTORS OF THE ISSUER
- EX-99.6ea026254001ex99-6_crystal.htm
DEED OF ADHERENCE BY ADJUVANT FUND AND ADJUVANT FUND DE DATED OCTOBER 5, 2025
- EX-99.7ea026254001ex99-7_crystal.htm
DEED OF ADHERENCE BY SUPERSTRING CAPITAL DATED OCTOBER 27, 2025
- EX-99.8ea026254001ex99-8_crystal.htm
DEED OF ADHERENCE BY MSA GROWTH DATED OCTOBER 27, 2025
- EX-99.9ea026254001ex99-9_crystal.htm
DEED OF ADHERENCE BY EPIPHRON CAPITAL DATED OCTOBER 27, 2025
Issuer
Crystal Peak Investment Inc.
CIK 0002078050
Related Parties
1- filerCIK 0002078050
Filing Metadata
- Form type
- SCHEDULE 13D/A
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 8:05 AM ET
- Size
- 392.2 KB